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INTRODUCTION
The International Continence Society (ICS) derived the 
terminology of lower urinary tract function [1], and this is 
the main basis for the wordings and definitions used most 
widely in clinical practice. Although overactive bladder 
syndrome is comparatively well understood, its analogous 
counterpart, underactive bladder (UAB) syndrome is 
relatively underresearched. There has been much interest 
generated in this topic in recent years and efforts made to 
reach professional consensus on symptomatic definitions.
There are common linkages of  lower urinary tract 
symptoms (LUTS) which can be used to derive symptom 
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syndromes. The best recognised of this is overactive bladder 
(OAB), which is the existence of urgency with or without 
urgency urinary incontinence usually with increased 
daytime frequency and nocturia [2]. The importance of this 
symptom syndrome is the ability to identify individuals 
who potentially incurred benefit from specific intervention 
to reduce the severity of their LUTS. The usual approach 
is to give fluid advice, recommend bladder training and 
to consider pharmaceutical interventions. This approach 
enables wider recognition of problems and institution of 
initial therapy in primary care settings. “Overactive bladder” 
is generally considered a reasonably clear term by most 
patients, and intuitively fits with how they perceive their 
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own symptoms. When investigated further by healthcare 
professionals, patients with OAB are sometimes identified 
as having detrusor overactivity (DO). This is a urodynamic 
observation of  bladder contractions during filling which 
may be spontaneous or provoked [1]. Alternatively, there 
may be findings of inflammation in the lower urinary tract 
or some other factor which might sensitise the sensory 
nerves from the lower urinary tract. Thus the storage LUTS 
are largely encompassed by a symptom syndrome (OAB) 
and urodynamic observation (DO). These 2 terms are not 
interchangeable, since OAB patients may not have DO on 
filling cystometry; likewise DO may occur with no associated 
urgency. A similar approach to voiding LUTS, based on a 
symptom syndrome and a urodynamic observation, seems 
to be a legitimate aspiration in further developing the field. 
Detrusor underactivity (DU), an increasingly recognised 
cause of troublesome LUTS, is proposed as the analogous 
urodynamic observation to the UAB symptom complex [3,4]. 
Normal voiding is a complex process reliant on several 
potentially vulnerable contributors throughout the lower 
urinary tract and the neuraxis [5]. The bladder is a mus­
cular organ with the detrusor constituting the muscle 
responsible for pressure generation, and hence voiding. The 
muscle is driven by its efferent innervation, which ramifies 
throughout the detrusor to trigger contraction. The efferent 
innervation derives from the autonomic parasympathetic 
nucleus in the sacral part of the spinal cord. In the storage 
phase, this nucleus is inhibited; during voiding, the descen­
ding drive to trigger detrusor contraction is received from 
the pontine micturition center [6]. The permissive signal that 
sets off the process of voiding is determined by the cerebral 
cortex, predominantly the prefrontal cortex, a particularly 
important area for decision­making and planning. This 
rather complex arrangement is responsible for ensuring 
voiding proceeds as a normal behavioural activity in the 
social context of the organism. Reflexes in the neuraxis also 
allows the ability to overcome perturbations which could 
otherwise impair or prevent voiding. For example, some 
adaptation of  bladder contraction strength may well be 
needed to overcome alterations in the dynamics of voiding [7], 
notably with change in position, or increasing bladder outlet 
obstruction (BOO) (a common feature in the aging male, as a 
result of intrusive enlargement of the prostate gland). Thus 
DU may often occur alongside other urodynamic problems 
such as DO, BOO, or urodynamic stress incontinence [8­
10]. The overlap of LUTS associated with these conditions, 
such as a slow flow, increased urinary frequency and 
incontinence [3,4,11], presents a further challenge for the 
isolation and definition of a UAB symptom complex which 
may be attributed to DU.
TERMINOLOGY OF UNDERACTIVE 
BLADDER
Urodynamically diagnosed DU is defined by the ICS 
as “a contraction of  reduced strength and/or duration, 
resulting in prolonged bladder emptying and/or a failure to 
achieve complete bladder emptying in a normal time span” 
[1]. However, the ICS definition of DU does not include any 
specific thresholds to identify reduced strength, reduced 
duration, prolonged voiding, completeness of bladder empty­
ing, or “normal” time span. Complex aetiologies that lead 
to DU [12­14] and lack of consensus of what constitutes a 
contraction of reduced strength and prolonged urination 
time [4], are some of the hindrances to having standardized 
parameters which define urodynamic DU. Nevertheless, 
studies which attempt to provide epidemiological data or 
elucidate symptoms that may be attributed to DU give 
indications of reasonable thresholds that can be considered. 
Urodynamic inclusion criteria for DU in some recent 
studies are given in Table 1. Uren et al. [15] and Gammie 
et al. [16] use a bladder contractility index (BCI) of  <100 
Table 1. Urodynamic inclusion criteria for detrusor underactivity in recent studies
Study Sample size with DU (n) Age (y) DU urodynamic diagnostic criteria
Abarbanel and Marcus (2007) [29] Male, 82; female, 99 ≥70 Qmax<10 mL/s, PdetQmax <30 cmH2O
Jeong et al. (2012) [9] Male, 632; female, 547 >65 Male: BCI<100
Female: PdetQmax ≤10 cmH2O and Qmax ≤12 mL/s
Hoag and Gani (2015) [8] Male, 25; female, 54 Mean: 59.2 (range, 19–90) BCI<100 and absence of identifiable BOO
Gammie et al. (2016) [16] Male, 129; female, 308 Median: male 63, female 55 Male: BCI<100, BOOI<20, BVE<90%
Female: PdetQmax <20 cmH2O and Qmax <15ml/s
Uren et al. (2017) [15] Male, 29; female, 15  Mean: 64 (range, 27–88) Male: BCI<100 and BOOI <20
Female: PdetQmax of <20 cmH2O and Qmax of <15 mL/s
PdetQmax, detrusor pressure at maximum flow; Qmax, maximum flow rate; BCI, bladder contractility index; BOOI, bladder outlet obstruction in-
dex; BVE, bladder voiding efficiency. 
BCI=PdetQmax+5Qmax. BOOI=PdetQmax–2Qmax. BVE=(voided volume/total bladder capacity)×100.
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and a bladder outlet obstruction index (BOOI) of  <20 in 
men. The acceptable degree of BOO is therefore restricted, 
with the result that patients with likely coexisting DU 
and BOO are excluded (those with a low BCI yet relatively 
high BOOI). Women were required to have a detrusor 
pressure at maximum flow (PdetQmax) of <20 cmH2O and 
a maximum flow rate (Qmax) of <15 mL/s. These thresholds 
were later endorsed by Fode and Sønksen [17]. However, 
these parameters are not likely to be definitive, given the 
ongoing research efforts of many, and further complications 
introduced through the proposed classification by aetiology 
[18].
Working back from this nonspecific definition of DU, a 
working symptomatic definition for UAB was derived by a 
consensus group at the 2014 International Consultation on 
Incontinence – Research Society as follows; “The underactive 
bladder is a symptom complex suggestive of detrusor 
underactivity and is usually characterised by prolonged 
urination time with or without sensation of incomplete 
bladder emptying, usually with hesitancy, reduced sensation 
on filling, and a slow stream” [3]. However, the need for 
further qualitative and quantitative research on which a 
symptomatic UAB definition may be based was increasingly 
recognised [3,4,19]. The latest symptomatic definition pro­
posed by a Working Group set up by the ICS in 2016 is: 
“Underactive bladder is characterised by a slow urinary 
stream, hesitancy and straining to void, with or without 
a feeling of incomplete bladder emptying and dribbling, 
often with storage symptoms” [20]. The ICS Working Group 
gives some explanatory notes. Firstly, that UAB “occurs in 
association with diverse pathologies and based on current 
knowledge there is no single distinguishing symptom.” This 
is in contrast to OAB, for which urgency is the central defi­
ning symptom. Secondly, that “storage symptoms in UAB 
are varied and may be highly prevalent, including nocturia, 
increased daytime frequency, reduced sensation of filling, and 
incontinence”. Finally, “underlying mechanisms of storage 
symptoms are diverse and are often related to a significant 
post voiding residual urine volume.” Recent contributions 
by Dewulf et al. [18] and Fode and Sønksen (2017) [17] also 
recognise the potential overlap of  symptoms with BOO 
within their definitions. Fode and Sønksen [17] give theirs as: 
“Underactive bladder is the subjective feeling of prolonged 
urination time, slow stream, and hesitancy, which may or 
may not be associated with poor bladder emptying and 
subsequent storage symptoms in men and women without 
evidence of any outlet obstruction.”
Crucially, the terminology used must meet the needs of 
both patients and healthcare professionals. The days when 
obscure terms were used by professionals regardless of 
whether the patient was able to identify their own position 
with the descriptive terms are receding. It is a specific 
expectation that communication between professionals 
and patients should be transparent and understandable. 
Underactive bladder is a comparatively simple term, and 
one that is reasonably straightforward for patients to take 
on board. There are some distinct weaknesses, nonetheless. 
The word “bladder” identifies a specific organ, yet it is not 
definite that that particular organ is necessarily the basis of 
the problem in all individuals. Furthermore, the bladder has 
definite fundamental tasks for which it has very contrasting 
behaviours. Specifically, storage requires minimal activity 
of  the bladder while voiding requires active contraction. 
Because the terminology does not make the contrasting 
storage and voiding functions clear, patients can often be 
confused by the possibility that they could have both an 
OAB and an UAB, and the healthcare professional then 
has to explain the relationship between these terms and the 
micturition cycle. No consensus has yet been achieved on 
how to overcome this limitation. Healthcare professionals 
do not generally have any problem with technical terms 
like detrusor underactivity. However, the limitation here is 
the vague description that has to be employed in defining 
it. Since there is no normative data or clear cut thresholds, 
the term is vague in its description, and rather discursive. 
Healthcare professionals tend to be rather dismissive of the 
term as a result, even though it is absolutely certain that 
some patients do genuinely manifest weakness of  their 
bladder contractility when attempting to void.
SYMPTOMS OF UNDERACTIVE  
BLADDER
The symptoms important to patients may ref lect 
underlying DU, but this may be compounded by additional 
lower urinary tract dysfunctions. In a large scale analysis 
of a UK database, Gammie et al. [16] have recently made 
attempts to identify differences in relative occurrence of the 
signs and symptoms of patients with urodynamic DU, in 
comparison with patients with BOO and those with ‘normal’ 
pressure flow studies (PFS). Many symptoms and medical 
history factors showed a statistically significant difference 
in relative occurrence. In male patients, the symptoms of 
decreased urinary stream (56% in patients with DU, 82% 
of patients with BOO, and 30% in those with normal PFS) 
and hesitancy (51% in DU, 69% BOO, 26% with normal 
PFS 26%) were in high frequency. In women, a decreased 
urinary stream was present in 29% of DU patients, 20% of 
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BOO patients and 4% of those with normal PFS. However, 
as symptoms that were specific to a particular group were 
low in frequency, and the relative differences in symptom 
occurrence generally indistinct; information that could be to 
symptomatically differentiate DU from BOO still remains 
unclear [20].
In a qualitative study by Uren et al. [15] storage LUTS 
(noc turia, increased daytime frequency, urgency, and incon­
tinence), and voiding symptoms (slow stream, hesitancy, and 
straining) were reported by over half the patients with DU. 
Table 2 lists the commonly reported symptoms in this study. 
The symptom of straining (which patients may employ to 
initiate, maintain, or finish urination) is of particular note 
as it common in the group of patients with DU in isolation. 
Straining is not included in some important symptomatic 
definitions of UAB [3]. However, it was included in the more 
recent definition of the ICS Working Group [20]. Storage 
symptoms were key to the patient reported UAB experience 
with a high prevalence of spontaneous reporting and often 
severe associated bother. However, the notable observation 
of incontinence was mostly attributed to the inclusion of 
a group with DU and coexisting DO or SUI. Nocturia was 
the most commonly reported symptom but the underlying 
aetiology of nocturia is complex and age­related [21,22], so 
ascertaining the underlying mechanism and to what extent 
nocturia can be attributed to DU is uncertain. Post voiding 
symptoms, including a sensation of incomplete emptying, the 
need to revoid within a short period of time, and dribbling, 
were also frequently reported in the sample. A few patients 
described a perceived reduction in sensation of the fullness 
of the bladder, similar to the phrasing in the symptomatic 
definition (‘reduced sensation on filling’) [3]. As might 
be expected from other studies [8], many had a postvoid 
residual (PVR) (77% had a PVR of >30 mL) and perhaps 
correspondingly, there was a high proportion of patients 
who were historically or currently self­catheterising and 
experienced UTIs. 
IMPACT OF UNDERACTIVE BLADDER
Qualitative research into the impact of LUTS show that 
there can be a broad impact on patients’ lives associated with 
these symptoms [23­25]. Disruption to sleep due to waking 
several times in the night and the lifestyle inconveniences 
caused by increased daytime urinary frequency can be 
particularly bothersome. The necessity to plan ahead for 
awareness of the location of toilets, impairment of social life, 
embarrassment in particular situations and reduced self­
esteem are a feature of qualitative studies in male patients 
with LUTS [25,26]. However, overall, UAB does appear to be 
a condition that can often be tolerated and well­managed 
by patients. Patients in Uren et al. [15] described how they 
adapt their lives around their condition so that impact 
was minimised, asserting that they had become ‘used to it,’ 
perhaps due to the chronic nature of their condition. This 
also appears to be the case in other studies investigating the 
impact on patients with LUTS [25,27].
PRESENTATION AND DIAGNOSIS OF  
UNDERACTIVE BLADDER
The ongoing scientific debate surrounding the de finitions 
of DU/UAB and that DU is fundamentally a urodynamic 
observation, means the extent of  the underlying contri­
bution of  DU to the prevalence of  LUTS in the general 
population is difficult to establish [28]. However, the current 
epidemiological research for DU suggests it is a commonly 
a factor in men and women presenting with LUTS. In 
referred populations who have undergone urodynamic 
studies, the prevalence of DU was 40% of men and 13% of 
women [9], and as much as 48% in male patients >70 years 
of age [29].
As a primary condition, individuals affected by UAB 
may constitute a group of  people which is not widely 
recognised in the healthcare professions, as they may not 
present if  their only symptoms are voiding LUTS. From 
research into OAB, it is clear that voiding LUTS tend 
to be rather less problematic to patients in their day­to­
day lives than storage LUTS [27]. Many patients with a 
comparatively poor stream or mild hesitancy may not give 
Table 2. Commonly reported signs and symptoms of underactive 
bladder (based on Uren et al. [15])
Symptoms
   Slow (and or interrupted) stream of long duration and of small volume
   Increased daytime urinary frequency
   Nocturia
   Straining
   Hesitancy
   Sensation of incomplete emptying
   Urgency
   Urinary incontinence
   Postmicturition dribble
   Reduced bladder sensation
   Bladder discomfort or pain
Signs
   High postvoid residual
   History of urinary tract infections
   History of acute retention episodes
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this sufficient priority to present to healthcare professionals 
for assessment. Presentation probably becomes more likely 
if  storage LUTS emerge. Patients are substantially more 
bothered by urgency, nocturia and increased daytime 
frequency [27] and this may well be the factor that prompts 
a medical presentation. Such a situation can emerge if 
patients develop incomplete bladder emptying, resulting in a 
PVR. This probably reduces the functional bladder capacity, 
resulting in an increased daytime frequency and perhaps 
urgency and nocturia. However, it is important to recognise 
that the PVR is not necessarily the sole driver of storage 
LUTS in people with an UAB. Some patients may present 
with voiding LUTS in combination with storage LUTS and 
only a modest PVR (Fig. 1). This paradoxical situation, if 
investigated urodynamically, tends to show a stable detrusor 
during filling, as illustrated, even though a symptom score 
and bladder diary suggest urgency and small typical voided 
volumes. Recently, some theoretical physiology has been 
advanced to try to explain this [30].
UAB may become a feature in a secondary setting, for 
example, if medications, neurological disease or autonomic 
disease leads to impairment of  the detrusor contraction. 
This is more likely to become an issue for those patients 
with additional challenges for lower urinary tract function, 
for example, the presence of benign prostate enlargement 
in men, giving rise to the need for raised detrusor pressure 
to achieve urination (i.e., BOO), since DU impairs this 
compensatory increased contraction. Invasive urodynamics 
is currently used to differentiate suspected DU from BOO 
as there may be little benefit to corrective surgery for 
LUTS in patients with DU [31]. Indeed, there would be 
considerable advantage for patients and clinical practice if it 
was possible to differentiate these conditions by noninvasive 
means. Further work such as the ongoing development 
of a validated, condition­specific patient reported outcome 
instrument [15,32], along with employing techniques such 
as penile cuff­urodynamics [33] and ultrasonographic 
measurement of  detrusor wall thickness [34] may add 
additional diagnostic information. However these methods 
have not yet been evaluated by clinical trials.
CONCLUSIONS
People experience voiding as a rather transient and 
minor aspect of their day­to­day lives. They are unaware of 
the complexities underlying voiding and simply expect it to 
be a prompt, efficient and complete process, conveniently 
achieved at the timing that suits them best. Whenever 
Fig. 1. A young male patient (aged 36 
years) presenting with storage, voiding 
and postmicturition LUTS. Urodynamic 
trace of the end of the filling cystometry 
and the pressure flow study (PFS), illustrat-
ing rectal pressure (red), bladder pres-
sure (blue), subtracted detrusor pressure 
(green), and flow (black). Permission to 
void was given at 1, and a slowly-building 
detrusor contraction results, which the 
patient augments with abdominal strain-
ing at 2. Flow took a minute to start, and 
reached peak flow (Qmax) at point 3. De-
trusor pressure was 35 cmH2O and Qmax 
was 9 mL/s (bladder contractility index 80, 
which is below the threshold for normal of 
100). The detrusor contraction concludes 
at 4, giving a total duration for the PFS of 
two and a half minutes.
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this is their actual experience, it is unlikely that a normal 
individual would give it much further thought. People 
referred for urodynamic tests may be found to have a 
weak and poorly sustained detrusor contraction, termed 
detrusor underactivity. When the presenting symptoms of 
these people are reviewed, they encompass storage, voiding 
and postvoiding LUTS. Bringing them together, the ICS 
Working Group describes UAB as being characterised by 
a slow urinary stream, hesitancy, and straining to void, 
with or without a feeling of incomplete bladder emptying 
and dribbling, often with storage symptoms. Presentations 
are driven by the most bothersome symptoms, which 
rather paradoxically in UAB appear to be storage LUTS. 
The exact contribution of  UAB in the context of  the 
coexisting urological conditions which commonly present is 
a conundrum which needs to be addressed by healthcare 
professionals for each individual patient. 
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